BioSymetrics
BioSymetrics is a phenomics-driven drug discovery founded in 2015 by Anthony Iacovone.
1
Funding Rounds
$5.9m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| An***** Ia****** |
|
- | |
| Ga***** Mu*** | - | - | - |
Industries
BioSymetrics is active in the following industries: